Conventional prostate cancer treatments increase risk of blood clots by 250 percent

Here is a reason to take pause with traditional gold standard prostate cancer surgery:

A recent study published in The Lancet Oncology has found that men with prostate cancer are twice as likely as healthy men to suffer a blood clot, and those with the disease who undergo certain conventional treatments are at an even greater risk.

The study involved 76,000 Swedish men who were evaluated based on the number of cases of deep-vein thrombosis (DVT), pulmonary embolism and arterial embolism that occurred. Participants on hormone therapy were twice as likely to suffer a pulmonary embolism and two-and-a-half times more likely to have DVT than those who did not receive the treatment.

Similar results were observed for those receiving curative prostate cancer treatments. Pulmonary embolism risk doubled as a result of the treatment while DVT risk increased by 173 percent.

Click here for the complete article.